The recommendation by the CHMP should now result in approval of Arexvy in the broader age range in February next year, and ...

It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.

GSK said on Friday a panel ‍of the European Medicines Agency had backed the use of its ‌respiratory syncytial ‌virus (RSV) ...

In the third quarter, our revenue were $1 billion, driven by sales of our fully approved vaccines, Spikevax, mNEXSPIKE, ...

Jefferies initiated coverage of Moderna (MRNA) with a Hold rating and $30 price target For 2026, the company’s Covid and RSV sales should grow ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed seven new medicines for approval this ...

The FDA is reviewing RSV vaccines, which have drastically lowered infant hospitalizations, a spokesperson confirmed ...

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...